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Abstract
Path-specific effects (PSEs) are a critical measure for assessing mediation in the presence of
multiple mediators. However, the conventional definition of PSEs has generated controversy
because it often causes misinterpretation of the results of multiple mediator analysis. For indepth analysis of this issue, we propose the concept of decomposing fully mediated interaction
(FMI) from the average causal effect. We show that FMI misclassification is the main cause of
PSE misinterpretation. Two strategies for specifying FMI are proposed: isolating FMI and
reclassifying FMI. The choice of strategy depends on the objective. Isolating FMI is the superior
strategy when the main objective is elucidating the mediation mechanism whereas reclassifying
FMI is superior when the main objective is precisely interpreting the mediation analysis results.
To compare performance, this study used the two proposed strategies and the conventional
decomposition strategy to analyze the mediating roles of dyspnea and anxiety in the effect of
impaired lung function on poor health status in a population of patients with chronic obstructive
pulmonary disease. The estimation result showed that the conventional decomposition strategy
underestimates the importance of dyspnea as a mechanism of this disease. Specifically, the
strategy of reclassifying FMI revealed that 50% of the average causal effect is attributable to
mediating effects, particularly the mediating effect of dyspnea.
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Introduction
Causal mediation analysis with multiple mediators is an important technique for investigating
biologic or mechanistic pathways that contribute to the average causal effect (ACE) of an
exposure or treatment on an outcome. Typically, path-specific effects (PSEs) decomposed from
ACE are derived to explain how exposure affects an outcome through different mediation paths
1

. However, most PSEs cannot be identified nonparametrically1,2. To this end, numerous

researchers have considered different assumptions and conditions for identifying PSEs 2-9 in a
counterfactual framework

10,11

. The most common conventional strategy is deriving the

identifiable path effects through sequential effect decomposition2,7,12-14 (also called partially
forward decomposition strategy

15

or three-way decomposition strategy for two mediators 6).

For K ordered mediators, this approach decomposes ACE into K+1 components: one
component is the direct effect, and the remaining K PSE components are indirect effects
corresponding to K mediators. In this article, K+1 PSEs obtained by sequential effect
(𝑆0)

decomposition are referred to as {PSE𝑘

(𝑆0)

; 𝑘 = 0,1, … , K}. The {PSE𝑘

; 𝑘 = 0,1, … , K} can

be viewed as the direct extension of natural direct and indirect effects (the standard
decomposition of ACE in the case of one mediator

16

). The 𝑆0 represents the conventional

sequential effect decomposition strategy. Moreover, Steen, et al.

6

noted that this strategy

maximizes the precision of decomposition performed under multiple ordered mediators without
introducing sensitivity parameters or parametric assumptions. Sequential effect decomposition
strategy has also been successfully integrated in statistical models applied in various contexts,
including analyses of survival

7,12,13

, continuous outcomes2, and dichotomous mediators and

outcomes14.
Although sequential effect decomposition is the conventional approach that has proven
(𝑆0)

most effective in previous works, causal interpretations of {PSE𝑘

; 𝑘 = 0,1, … , K} have not

been fully investigated. Therefore, this study specifically discussed the misinterpretation issue
2

in sequential effect decomposition. According to the intervention scheme for exposing a
(𝑆0)

exposure on mediators, PSE with respect to the kth mediator (i.e., PSE𝑘

) is used to assess

how the effect of an exposure on an outcome is mediated through a specific set of paths, which
starts at the kth mediator. This PSE type is also referred to as a mediator-leading indirect effect
since the path of mediation is led by the corresponding mediator variable15. However, the
(𝑆0)

conventional definition of PSE𝑘

does not reflect this “mediator-leading” property.
(𝑆0)

Therefore, inferring mediation based on {PSE𝑘

; 𝑘 = 0,1, … , K} may obtain a misleading

interpretation. The key cause of misinterpretation is that sequential effect decomposition does
not consider interaction. To explain this phenomenon, we propose a novel component
decomposed from ACE: fully mediated interaction (FMI). The derivation of FMI is inspired by
the four-way decomposition developed by VanderWeele 17, which disentangles interaction and
mediation from ACE. The FMI explains how the effect of the exposure changes when the
outcome results from a complex interaction among full or partial mediator variables. In this
study, we demonstrate why the sequential effect decomposition approach misclassifies FMI,
which causes misinterpretation in multiple mediation analysis.
To remedy this problem, this study first clarifies the role of FMI by comprehensively
extracting its underlying mechanism. We show that FMI can be reduced to a mediated
interaction, as described in Taguri, et al.

18

, under a parallel mediation structure. When

mediators are causally ordered, FMI captures more interaction details compared to the Taguri
mediated interaction. Next, we propose two alternative strategies for decomposing ACE to
enhance interpretation of multiple mediation analysis results: the isolate FMI strategy and the
reclassify FMI strategy. The choice of strategy depends on the specific objectives and
requirements of the investigator and on the specific conditions of the analysis. The reclassify
(𝑆0)

FMI strategy suggests an alternative definition of PSE𝑘

, and PSEs obtained by this strategy

can perfectly reflect the effects along with expected interpretations. We demonstrate the

3

application of the two strategies in analysis of chronic obstructive pulmonary disease (COPD).
Specifically, we explore the mediating roles of dyspnea and anxiety in the effect of impaired
lung function on poor health status.

Methods
Notation and Causal diagram
Let 𝐴 denote the exposure, 𝑌 denote the outcome of interest, 𝑀1 and 𝑀2 denote the
two causally ordered mediators, and 𝐶 denote the baseline confounders. Figure 1 depicts the
causal structure as a directed acyclic graph. Next, we introduce the counterfactual outcome
model

16

. Let 𝑌(𝑎) , 𝑀1 (𝑎) and 𝑀2 (𝑎) denote the counterfactual values of

𝑌 , 𝑀1 and

𝑀2 , respectively, when A is set to 𝑎. Similarly, let 𝑌(𝑎, 𝑚) denote the counterfactual value
of 𝑌 when 𝑀 is set to 𝑚 and 𝐴 is set to 𝑎. Moreover, the cross-world counterfactual is
defined as follows: 𝑀2 (𝑎, 𝑀1 (𝑎∗ )) is the counterfactual value of 𝑀2 when 𝐴 is set to 𝑎
and 𝑀1 is set to 𝑀1 (𝑎∗ . Note that 𝑎 and 𝑎 ∗ are two arbitrary numbers. The following
discussion focuses on a binary exposure where the values of 𝑎 and 𝑎∗ are in {0,1}.

Figure 1 Causal diagram with exposure 𝐴, two causally ordered mediators 𝑀1 and 𝑀2, outcome 𝑌, and
baseline confounders 𝐶

PSE via the conventional sequential effect decomposition
Avin, et al. 1 extended the causal mediation analysis framework16,19 by applying the PSE
4

concept in cases of multiple mediators. The authors decomposed ACE into several components
corresponding to mediation paths. In cases with two causally ordered mediators, four PSE paths
were defined: the path not through 𝑀1 and not through 𝑀2 , the path through 𝑀1 but not
through 𝑀2 , the path through 𝑀2 but not through 𝑀1 , and the path through 𝑀1 and through
𝑀2 ; the four paths were designated 𝑃𝑆𝐸0 , 𝑃𝑆𝐸1 , 𝑃𝑆𝐸2 , and 𝑃𝑆𝐸12 , respectively. However, a
complete decomposition {𝑃𝑆𝐸0 , 𝑃𝑆𝐸1 , 𝑃𝑆𝐸2 , 𝑃𝑆𝐸12 } from ACE is not parametrically
identifiable

1

. When additional sensitivity parameters are not needed to characterize

relationships among mediators2, sequential effect decomposition6,15 is the strategy most
commonly used to define identifiable PSEs in the literature7,12-14. This strategy decomposes
ACE into three effects: the effect in the absence of mediators, the effect through 𝑀1 (i.e.,
regardless of the effect through 𝑀2 , the effect first through 𝑀1 then 𝑀2 should be included
(𝑆0)

in 𝑃𝑆𝐸1 ), and the effect through 𝑀2 only. As we denoted above, these effects are 𝑃𝑆𝐸0
(𝑆0)

𝑃𝑆𝐸1

(𝑆0)

and 𝑃𝑆𝐸2

,

. Figure 2 illustrates the paths accounted for by each effect under

sequential effect decomposition. Based on the counterfactual model, these effects are defined
as follows:
(𝑆0)

= ϕ(1,0,0) − ϕ(0,0,0)

(𝑆0)

= ϕ(1,1,0) − ϕ(1,0,0)

(𝑆0)

= ϕ(1,1,1) − ϕ(1,1,0)

𝑃𝑆𝐸0
𝑃𝑆𝐸1

𝑃𝑆𝐸2

where ϕ(𝑎1 , 𝑎2 , 𝑎3 ) ≡ 𝐸 [𝑌 (𝑎1 , 𝑀1 (𝑎2 ), 𝑀2 (𝑎3 , 𝑀1 (𝑎2 )))].
(𝑆0)

Although many statistical models have been proposed for estimating 𝑃𝑆𝐸0
(𝑆0) 6,7,12

and 𝑃𝑆𝐸2

(𝑆0)

, 𝑃𝑆𝐸1

, the sequential effect decomposition defined above has two limitations. First,

definitions of PSE widely vary according to the reference exposure level. For example,
(𝑆0)

𝑃𝑆𝐸2

can be alternatively defined as ϕ(0,1,1) − ϕ(0,1,0) , ϕ(1,0,1) − ϕ(1,0,0) , or

ϕ(0,0,1) − ϕ(0,1,0). Other PSEs also apply alternative definitions. One solution proposed by
Daniel et al is to calculate PSE according to all proposed definitions and then apply the average
5

value2. However, an ongoing controversy is what exposure level should be selected for the
(𝑆0)

reference value. Second, the conventional definition of 𝑃𝑆𝐸2
(𝑆0)

further decomposition of 𝑃𝑆𝐸2

is questionable because a
(𝑆0)

reveals that two components in 𝑃𝑆𝐸2
(𝑆0)

the mediation effect of 𝑀2 . It implies that 𝑃𝑆𝐸2

are irrelevant to

is inappropriate for characterizing the

mediation role of 𝑀2 . The next section formulates the second limitation, which is inspired by
VanderWeele mediation-interaction analysis 17. We then propose a plausible definition of PSEs
in the presence of multiple ordered mediators.

Figure. 2. Path illustration of path-specific effects (PSEs) under sequential effect decomposition with
exposure 𝐴, two causally ordered mediators 𝑀1 and 𝑀2 , and outcome 𝑌.

Misclassified component in 𝑷𝑺𝑬𝑺𝟎
𝟐 − FMI
To illustrate the issue that occurs in sequential effect decomposition, we further
(𝑆0)

decompose 𝑃𝑆𝐸2

( = ϕ(1,1,1) − ϕ(1,1,0) ) into two components: ϕ(1,0,1) − ϕ(1,0,0)

and [ϕ(1,1,1) − ϕ(1,1,0)] − [ϕ(1,0,1) − ϕ(1,0,0)] . As mentioned above, the first
(𝑆0)

component is an alternative definition of 𝑃𝑆𝐸2

, where the reference level of exposure

mediated by 𝑀1 is set to 0 instead of 1. This component explicitly captures the mediating
6

effects of 𝑀2 . Only the reference level of exposure that intervenes in 𝑀1 is set to zero,
implying the path from 𝐴 to 𝑀1 has been cut off. The second component is fully mediated
interaction (FMI), which mostly comprises full interacting effects in the path through 𝑀1 and
(𝑆0)

𝑀2 . Classifying FMI into 𝑃𝑆𝐸2

can be problematic when interpreting causal mediation

effects. Specifically, FMI captures effects corresponding to paths including 𝐴 → 𝑀1 . In the
absence of a causal effect of 𝐴 on 𝑀1 , 𝑀1 (1) = 𝑀1 (0), and FMI is equal to zero. According to
(𝑆0)

the interpretation of 𝑃𝑆𝐸2

(𝑆0)

(i.e., the effect through 𝑀2 only), including FMI in 𝑃𝑆𝐸2

is

inappropriate.
Additionally, we further investigate the details of all FMI components to determine
(𝑆0)

whether FMI should belong to 𝑃𝑆𝐸1

or other. For simplicity of discussion, the analysis can

be simplified as a decomposition of individual-level FMI (iFMI) as follows:
iFMI = 𝑌 (1, 𝑀1 (1), 𝑀2 (1, 𝑀1 (1))) − 𝑌 (1, 𝑀1 (1), 𝑀2 (0, 𝑀1 (1)))
− 𝑌 (1, 𝑀1 (0), 𝑀2 (1, 𝑀1 (0))) + 𝑌 (1, 𝑀1 (0), 𝑀2 (0, 𝑀1 (0))).
The iFMI is decomposed into iFMIpure and iFMIendo , where
iFMIpure = [𝑌(1,1,1) − 𝑌(1,1,0) − 𝑌(1,0,1) + 𝑌(1,0,0)] [𝑀1 (1) − 𝑀1 (0)] [𝑀2 (1,0) −
𝑀2 (0,0)] and
iFMIendo = [𝑌(1,1,1) − 𝑌(1,1,0)] [𝑀1 (1) − 𝑀1 (0)] [𝑀2 (1,1) − 𝑀2 (1,0) − 𝑀2 (0,1) +
𝑀2 (0,0)].
The proof in Appendix A further disentangles the underlying mediation paths of iFMIpure and
iFMIendo . Figure 3 illustrates the mediation paths. iFMIpure and iFMIendo are the mediated
interactive effects of 𝐴 on 𝑌, which is a measure of interaction 20, but iFMIpure and iFMIendo
are induced by different mechanisms. The iFMIpure purely captures mediating effects of the
interaction between 𝑀1 and 𝑀2 on 𝑌 . The first term ( 𝑌(1,1,1) − 𝑌(1,1,0) − 𝑌(1,0,1) +
𝑌(1,0,0)) represents the mediating effects of the interaction between 𝑀1 and 𝑀2 on Y, and
the second and third terms (i.e., 𝑀1 (1) − 𝑀1 (0) and 𝑀2 (1,0) − 𝑀2 (0,0), respectively) imply
7

that both 𝑀1 and 𝑀2 are induced by 𝐴. Taguri, et al. 18 introduced the concept of iFMIpure in
the context of multiple parallel mediators. They decomposed the indirect effect into three paths:
the path through 𝑀1 , the path through 𝑀2 , and the path through interaction between 𝑀1 and
𝑀2 on Y, which they termed the “mediated interaction (MI)”.

Notably, their use of the term

MI differed from the use of the term MI in the VanderWeele four-way decomposition17, which
referred to the interaction among exposure and mediator. The Taguri’s MI is the same as
iFMIpure proposed in the current study, and the Taguri’s MI can generally be decomposed from
our iFMI.
Unlike iFMIpure , which describes how a mediated interaction affects outcome, iFMIendo
describes the effect of an endogenously mediated interaction, i.e., a mediated interactive effect
on a subsequent mediator rather than on an outcome. In the case of two ordered mediators,
iFMIendo captures all effects in which the mediated interaction between 𝑀1 and 𝐴 induces
𝑀2 and then 𝑀2 induces 𝑌 (i.e., 𝑌(1,1,1) − 𝑌(1,1,0) ). This mediated interaction
corresponds to the product of the second term (𝑀1 (1) − 𝑀1 (0)) and third term (𝑀2 (1,1) −
𝑀2 (1,0) − 𝑀2 (0,1) + 𝑀2 (0,0)), which precisely corresponds to the “mediated interaction” in
the VanderWeele’s four-way decomposition17 when the mediator is replaced by 𝑀1 and the
outcome is replaced by 𝑀2 . In the illustrative example, iFMIendo specifically assesses how the
interaction between lung function impairment (𝐴) and dyspnea (𝑀1 ) affects anxiety (𝑀2 ) and
then anxiety causes a change in health-related quality of life (𝑌). The function of this complex
interaction requires that 𝑀1 and 𝑀2 have full roles in the mechanism. Therefore, classifying
(𝑆0)

iFMIendo into 𝑃𝑆𝐸1

is appropriate according to the natural interpretation of PSE in relation

to𝑀1 6,15. If mediators are causally independent, no endogenously mediated interactions occur,
and iFMIendo = 0. Thus, the Taguri’s MI and the proposed iFMI are identical when a parallel
mediation structure is assumed. This property reveals that iFMI is a generalization of the
Taguri’s MI.

8

Figure. 3. Underlying mediation paths of iFMIpure and iFMIendo with exposure 𝐴 , two causally
ordered mediators 𝑀1 and 𝑀2, and outcome 𝑌.

Two strategies for effect decomposition in two causally ordered mediators

We have shown the critical issue in the conventional sequential effect decomposition
strategy by introducing FMIpure and FMIendo , which are the population-level iFMIpure and
iFMIendo (i.e., 𝐸[iFMIpure ] and 𝐸[iFMIendo ] ). Unfortunately, FMIpure and FMIendo are
not generally separable and not identifiable without additional assumptions, and separating
FMIpure and FMIendo is beyond the scope of this study. The aims of this study were to
(𝑆0)

highlight misinterpretations of 𝑃𝑆𝐸1

(𝑆0)

and 𝑃𝑆𝐸2

resulting from sequential effect

decomposition and to suggest the most appropriate approach to analyzing multiple mediators.
(𝑆0)

Accordingly, we propose two strategies to remedy the problem of 𝑃𝑆𝐸1
explicitly specify the role of FMI.

Isolate FMI strategy: FMI-specific effect decomposition
9

(𝑆0)

and 𝑃𝑆𝐸2

and

The FMI-specific effect decomposition strategy isolates FMI from PSEs. Note that, while
FMIpure and FMIendo are not identifiable, FMI is identifiable without additional assumptions
for defining PSE. Therefore, the proposed strategy decomposes ACE into four components.
Based on the counterfactual model, FMI and three PSEs are defined below.
(𝑆1)

= ϕ(1,0,0) − ϕ(0,0,0)

(𝑆1)

= ϕ(1,1,0) − ϕ(1,0,0)

(𝑆1)

= ϕ(1,0,1) − ϕ(1,0,0).

𝑃𝑆𝐸0
𝑃𝑆𝐸1

𝑃𝑆𝐸2

FMI = [ϕ(1,1,1) − ϕ(1,1,0)] − [ϕ(1,0,1) − ϕ(1,0,0)].
In the isolate FMI strategy, definitions of 𝑃𝑆𝐸0𝑆1 and 𝑃𝑆𝐸1𝑆1 are identical to the conventional
(𝑆1)

definitions. The causal interpretations of these four effects are as follows: 𝑃𝑆𝐸0

is the effect

for the paths irrelevant to either 𝑀1 or 𝑀2 ; 𝑃𝑆𝐸1𝑆1 is the effect for the paths starting at 𝑀1
in any way, except the path of FMI with 𝑀2 ; 𝑃𝑆𝐸2𝑆1 is the effect for the path through 𝑀2
solely; FMI is the effect for fully mediated interaction paths through 𝑀1 and 𝑀2 . As
mentioned above, the effects obtained by the isolate FMI strategy correspond with the
decomposed effects proposed by Taguri, et al. 18 under a parallel mediation structure. In such a
(𝑆1)

case, 𝑃𝑆𝐸1

is simplified as the effect solely for the path through 𝑀1 , and FMI is the effect
(𝑆1)

of purely mediated interaction. The 𝑃𝑆𝐸1

and FMI quantify different mechanisms. Thus, if
(𝑆1)

mediators are causally independent, then 𝑃𝑆𝐸1

and FMI should be reported separately, and

the − isolate FMI strategy is superior.
For the ordered mediators in Figure. 1, decomposing FMI from ACE can still elucidate the
mechanism. In practice, however, quantifying FMI is rarely a primary research objective.
Moreover, the underlying mediation paths captured by FMIendo certainly pass through 𝑀1
and 𝑀2 sequentially (see Figure. 3), which indicates that the boundary between FMI and
(𝑆1)

𝑃𝑆𝐸1

(𝑆1)

is extremely vague from a mechanistic perspective. Therefore, FMI and 𝑃𝑆𝐸1

should be merged in the case of ordered mediators. Therefore, we suggest using an effect

10

decomposition method in the reclassify FMI strategy.
Reclassify FMI strategy: conversely sequential effect decomposition
To implement the reclassify FMI strategy, ACE is decomposed into the three following
components.
(𝑆2)

= ϕ(1,0,0) − ϕ(0,0,0)

(𝑆2)

= ϕ(1,1,1) − ϕ(1,0,1)

(𝑆2)

= ϕ(1,0,1) − ϕ(1,0,0).

𝑃𝑆𝐸0
𝑃𝑆𝐸1

𝑃𝑆𝐸2

Comparing effects between the isolate FMI strategy and the reclassify FMI strategy reveals
(𝑆2)

𝑃𝑆𝐸1

(𝑆1)

= 𝑃𝑆𝐸1

(𝑆2)

+ FMI and 𝑃𝑆𝐸2

(𝑆1)

= 𝑃𝑆𝐸2

. The effects obtained by the reclassify
(𝑆2)

FMI strategy are appealing for two reasons. First, {𝑃𝑆𝐸0

(𝑆2)

, 𝑃𝑆𝐸1

(𝑆2)

, 𝑃𝑆𝐸2

} in the

reclassify FMI strategy is an alternative to the conventional formulation of PSEs
(𝑆0)

{𝑃𝑆𝐸0

(𝑆0)

, 𝑃𝑆𝐸1

(𝑆0)

, 𝑃𝑆𝐸2

}. Thus, the identification assumptions of the reclassify FMI strategy

is identical to that of the conventional sequential effect decomposition strategy. Moreover, the
scheme for performing an exposure intervention in PSEs when using the reclassify FMI strategy
is converse to that in conventional PSEs when using sequential effect decomposition. Thus, the
reclassify FMI strategy is considered a conversely sequential effect decomposition. Second, the
reclassify FMI strategy enables a more precise interpretation of the expected mechanism
(𝑆1)

compared to conventional sequential effect decomposition. Similar to 𝑃𝑆𝐸2
(𝑆2)

FMI strategy, 𝑃𝑆𝐸2

in the isolate
(𝑆2)

precisely captures the effect mediated through 𝑀2 . The 𝑃𝑆𝐸1

fully

reflects the mediation mechanism, in which 𝑀1 is always activated. Meanwhile, if 𝑀2 is
activated, it should be induced by 𝑀1 regardless of whether the mechanism is mediation or
interaction. The general formulations of K mediators for the isolate FMI strategy and for the
reclassify FMI strategy are presented in Appendix B. Additionally, Table 1 compares sequential
effect decomposition between the isolate FMI strategy and the reclassify FMI strategy.
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Table 1. Comparison of isolate FMI strategy and reclassify FMI strategy.
Strategy

Definition

Interpretation

Recommendation
for use

Sequential effect decomposition
(𝑆0)

ϕ(1,0,0) − ϕ(0,0,0)

(𝑆0)

ϕ(1,1,0) − ϕ(1,0,0)

(𝑆0)

ϕ(1,1,1) − ϕ(1,1,0)

𝑃𝑆𝐸0
𝑃𝑆𝐸1

𝑃𝑆𝐸2

Effect corresponding to the paths irrelevant
to either 𝑀1 or 𝑀2
Effect corresponding to the paths starting
at 𝑀1 in any way, except the way of FMI
with 𝑀2
Effect corresponding to the paths through
𝑀2 solely and the paths present in FMI

There is no any
interaction among
variables.

Proposed Isolate FMI strategy
(𝑆1)

𝑃𝑆𝐸0

ϕ(1,0,0) − ϕ(0,0,0)

(𝑆1)

ϕ(1,1,0) − ϕ(1,0,0)

(𝑆1)

ϕ(1,0,1) − ϕ(1,0,0)

𝑃𝑆𝐸1

𝑃𝑆𝐸2

FMI

[ϕ(1,1,1) − ϕ(1,1,0)] −
[ϕ(1,0,1) − ϕ(1,0,0)]

(𝑆0)

The same as 𝑃𝑆𝐸0
The same as

(𝑆0)
𝑃𝑆𝐸1

Effect corresponding to the paths through
𝑀2 solely
Effect corresponding to the paths of
mediated interaction fully through 𝑀1 and
𝑀2

Interaction exists,
mediators are
causally independent,
and further

interested in
assessing FMI.

Proposed Reclassify FMI strategy
(𝑆2)

ϕ(1,0,0) − ϕ(0,0,0)

The same as 𝑃𝑆𝐸0

(𝑆2)

ϕ(1,1,1) − ϕ(1,0,1)

Effect corresponding to the paths starting
at 𝑀1

(𝑆2)

ϕ(1,0,1) − ϕ(1,0,0)

The same as 𝑃𝑆𝐸2

𝑃𝑆𝐸0
𝑃𝑆𝐸1

𝑃𝑆𝐸2

(𝑆0)

(𝑆1)

Interaction exists,
mediators are
causally dependent,
and interested in
assessing mediation
only.

Note: ϕ(𝑎1 , 𝑎2 , 𝑎3 ) ≡ 𝐸 [𝑌 (𝑎1 , 𝑀1 (𝑎2 ), 𝑀2 (𝑎3 , 𝑀1 (𝑎2 )))]; PSE: path-specific effect

Identification and assumptions
Since both strategies are defined by the counterfactual model, an identification process is
needed to link counterfactual values with observations. Based on previous studies,6,15 five
assumptions of the identification process are as follows: (1) exchangeability between outcome
and exposure, (2) exchangeability between outcome and mediators, (3) exchangeability
between mediators and exposure, (4) cross-world exchangeability between outcome and
mediators, and (5) cross-world exchangeability among mediators. Consequently, the estimators
of PSEs in the two strategies are shown below.
̂ 0(𝑆1) = 𝑄(1,0,0) − 𝑄(0,0,0); 𝑃𝑆𝐸
̂ 1(𝑆1) = 𝑄(1,1,0) − 𝑄(1,0,0)
Isolate FMI strategy: 𝑃𝑆𝐸
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̂ 2(𝑆1) = 𝑄(1,0,1) − 𝑄(1,0,0); FMI
̂ = [𝑄(1,1,1) − 𝑄(1,1,0)] − [𝑄(1,0,1) −
𝑃𝑆𝐸
𝑄(1,0,0)].
̂ 0(𝑆1) = 𝑄(1,0,0) − 𝑄(0,0,0); 𝑃𝑆𝐸
̂ 1(𝑆2) = 𝑄(1,1,1) −
Reclassify FMI strategy: 𝑃𝑆𝐸
̂ 2(𝑆2) = 𝑄(1,0,1) − 𝑄(1,0,0).
𝑄(1,0,1); 𝑃𝑆𝐸
In the above formulations of these estimators, 𝑄(𝑎1 , 𝑎2 , 𝑎3 ) represents the identified
expression of ϕ(𝑎1 , 𝑎2 , 𝑎3 ) in the form of
𝑄(𝑎1 , 𝑎2 , 𝑎3 ) = ∫

𝐸[𝑌|𝑐, 𝐴 = 𝑎1 , 𝑚1 , 𝑚2 ]𝑓(𝑚2 |𝑐, 𝐴 = 𝑎3 , 𝑚1 )𝑓(𝑚1 |𝑐, 𝐴

𝑐,𝑚1 ,𝑚2

= 𝑎2 )𝑓(𝑐)𝑑𝑚2 𝑑𝑚1 𝑑𝑐.
The detailed identification is given in Appendix C.

Estimation
In previous works, 𝑄(𝑎1 , 𝑎2 , 𝑎3 ) was estimated by using an imputation procedure6 and by
using inverse-probability-weighting15. Here, we illustrate the use of a standard regression-based
approach. For example, suppose that the outcome is consistent with the model
𝐸[𝑌|𝐶, 𝐴, 𝑀1 , 𝑀2 ]
= θ0 + θ𝑐 𝐶 + θ𝑎 𝐴 + θ1 𝑀1 + θ2 𝑀2 + θ𝑎1 𝐴𝑀1 + θ𝑎2 𝐴𝑀2 + θ𝑎12 𝐴𝑀1 𝑀2
+ θ12 𝑀1 𝑀2
with variance σ2𝑦 and with mediators that have the conditional mean
𝐸[𝑀1 |𝐶, 𝐴] = α0 + α𝑐 𝐶 + α𝑎 𝐴
𝐸[𝑀2 |𝐶, 𝐴, 𝑀1 ] = β0 + β𝑐 𝐶 + β𝑎 𝐴 + β1 𝑀1 + β𝑎1 𝐴𝑀1
with variances σ12 and σ22 . Specifying the interaction effects when modeling 𝑌 and 𝑀2 is a
critical step for our methodology because misinterpretation of conventional sequential effect
decomposition always arises in the presence of interaction. The estimator of 𝑄(𝑎, 𝑒1 , 𝑒2 ) is
given by
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𝑄(𝑎, 𝑒1 , 𝑒2 ) = θ0 + θ𝑎 𝑎 + θc 𝐸[𝐶] + [θ2 + θ𝑎2 𝑎][β0 + β𝑐 𝐸[𝐶] + β𝑎 𝑒2 ] + {θ1 + θ𝑎1 𝑎
+ [θ𝑎12 𝑎 + θ12 ][β0 + β𝑐 𝐸[𝐶] + β𝑎 𝑒2 ]
+ [θ2 + θ𝑎2 𝑎][β1 + β𝑎1 𝑒2 ]} [α0 + α𝑐 𝐸[𝐶] + α𝑎 𝑒1 ]
+ [θ𝑎12 𝑎 + θ12 ][β1 + β𝑎1 𝑒2 ] {[α0 + α𝑐 𝐸[𝐶] + α𝑎 𝑒1 ]2 + 𝜎1 }.
The estimators of PSEs in the isolate FMI strategy is derived as follows.
̂ 0(𝑆1) = 𝜃𝑎 + 𝜃𝑎2 [𝛽0 + 𝛽𝑐 𝐸[𝐶]] + {𝜃𝑎1 + 𝜃𝑎12 [𝛽0 + 𝛽𝑐 𝐸[𝐶]] + 𝜃𝑎2 𝛽1 }[𝛼0 + 𝛼𝑐 𝐸[𝐶]]
𝑃𝑆𝐸
2

+ 𝜃𝑎12 𝛽1 {[𝛼0 + 𝛼𝑐 𝐸[𝐶]] + 𝜎12 },
̂ 1(𝑆1) = {θ1 + θ𝑎1 + [θ𝑎12 + θ12 ][β0 + β𝑐 𝐸[𝐶]] + [θ2 + θ𝑎2 ]β1 }α𝑎
𝑃𝑆𝐸
+ [θ𝑎12 + θ12 ]β1 {2[α0 + α𝑐 𝐸[𝐶]]α𝑎 + α2𝑎 },
̂ 2(𝑆1) = [θ2 + θ𝑎2 ]β𝑎 + {[θ𝑎12 + θ12 ]β𝑎 + [θ2 + θ𝑎2 ]β𝑎1 } [α0 + α𝑐 𝐸[𝐶]]
𝑃𝑆𝐸
2

+ [θ𝑎12 + θ12 ]β𝑎1 {[α0 + α𝑐 𝐸[𝐶]] + σ12 }, and
̂ = {[θ𝑎12 + θ12 ]β𝑎 + [θ2 + θ𝑎2 ]β𝑎1 }α𝑎 + [θ𝑎12 + θ12 ]β𝑎1 {2[α0 + α𝑐 𝐸[𝐶]]α𝑎 + α2𝑎 }.
FMI
̂ = 0. This confirms the
If 𝐴 has no causal effect on 𝑀1 , α𝑎 = 0, which results in FMI
above conclusion that FMI captures the effects through paths from 𝐴 to 𝑀1 and should be
(𝑆0)

separated from 𝑃𝑆𝐸2

.

In the reclassify FMI strategy, PSE estimators are derived as follows.
̂ 0(𝑆2) = 𝜃𝑎 + 𝜃𝑎2 [𝛽0 + 𝛽𝑐 𝐸[𝐶]] + {𝜃𝑎1 + 𝜃𝑎12 [𝛽0 + 𝛽𝑐 𝐸[𝐶]] + 𝜃𝑎2 𝛽1 }[𝛼0 + 𝛼𝑐 𝐸[𝐶]]
𝑃𝑆𝐸
2

+ 𝜃𝑎12 𝛽1 {[𝛼0 + 𝛼𝑐 𝐸[𝐶]] + 𝜎12 },
̂ 1(𝑆2) = {θ1 + θ𝑎1 + [θ𝑎12 + θ12 ][β0 + β𝑐 𝐸[𝐶] + β𝑎 ] + [θ2 + θ𝑎2 ][β1 + β𝑎1 ]}α𝑎
𝑃𝑆𝐸
+ [θ𝑎12 + θ12 ][β1 + β𝑎1 ]{2[α0 + α𝑐 𝐸[𝐶]]α𝑎 + α2𝑎 }, and
̂ 2(𝑆2) = [θ2 + θ𝑎2 ]β𝑎 + {[θ𝑎12 + θ12 ]β𝑎 + [θ2 + θ𝑎2 ]β𝑎1 } [α0 + α𝑐 𝐸[𝐶]]
𝑃𝑆𝐸
2

+ [θ𝑎12 + θ12 ]β𝑎1 {[α0 + α𝑐 𝐸[𝐶]] + σ12 }.
According to the above estimators, the absence of any interaction (i.e., θ𝑎1 , θ𝑎2 , θ𝑎12 , and
β𝑎1 are zero) would ensure that the conventional strategy, the isolate FMI strategy, and the
reclassify FMI strategy are identical. This standard regression-based approach is simple and
efficient, but its drawback is the need for a new derivation each whenever the outcome or
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mediator models change. A simple remedy for this issue is using G-computation for Monte
Carlo sampling of counterfactual values of outcomes and mediators.

Illustration
The dataset used to illustrate the two strategies is the International Collaborative Effort on
Chronic Obstructive Lung Disease: Exacerbation Risk Index Cohorts (ICE COLD ERIC).
The ICE COLD ERIC study recruited 409 patients treated for COPD by general practitioners
in two European countries (the Netherlands and Switzerland) between 2008 and 2009. Fiveyear follow-up data for these patients are available to researchers. The initial inclusion criteria
for the study were a COPD diagnosis, age 40 years or older, and exacerbation-free status longer
than 4 weeks. More details of the study design are given in the study protocol 21.
Our aim was to investigate possible explanations for the effects of impaired lung function
at baseline on poor health status (feeling thermometer score) at the 4-year follow-up visit. The
mediators of interest were dyspnea score at the 6-month follow up and anxiety score at the 3year follow up. Figure 4 is the causal diagram.

In accordance with the modified Medical

Research Council Scale, dyspnea symptoms were graded from 0 (no symptoms) to 4 (almost
complete incapacity).

General health was measured using a feeling thermometer with a visual

analogue scale ranging from 0 (worse health status) to 100 (perfect health status). Mental health
was measured using the Hospital Anxiety and Depression Scale, which has a score range of 0
(lowest level of anxiety symptoms) to 21 (highest level of anxiety symptoms).

Medical

history was assessed at baseline in all patients. Demographic characteristics and medical history,
including nationality, gender, age, BMI and smoking, were treated as baseline confounders.
Table 2 presents the descriptive statistics for variables in this study.
Since forced expiratory volume in 1 second (FEV1) is the standard measure of lung
function impairment, patients were categorized into FEV1 stages I-IV (FEV1 ≥ 80%; 50-79%;
15

30-49%; < 30%, respectively). For illustrative purposes, lung function impairment was defined
as FEV1 < 50% (i.e., stages III-IV versus stages I-II). After excluding patients with missing
data, the final sample size was 220. Conventional PSEs were derived for the isolate FMI
strategy and for the reclassify FMI strategy. Table 3 presents the estimated PSEs, standard
deviations, 95% confidence intervals, and p-values. Bootstrapping was performed for inference
in this analysis. The critical finding in this analysis was the confirmation that FMI has a role in
the contribution of impaired lung function to poor health status. The results for the isolate FMI
strategy in Table 3 indicate that the effect of FMI was 2.013 (95% CI=(0.161, 3.864)), which
(𝑆1)

accounted for 16.8% of ACE. Additionally, the estimated 𝑃𝑆𝐸2

approached zero. Overall,

the present findings show that anxiety symptoms are not the sole mediator in the path from lung
function impairment to poor health status. The FMI has a major role in the effect of anxiety
symptoms on health status: specifically, synergistic interaction between anxiety and dyspnea
can affect health status, and anxiety can lead to poor health status when interaction between
lung function impairment and dyspnea contributes to anxiety symptoms.
Table 3 further reveals that the conventional approach underestimates the effect of lung
function impairment through the mediation path of dyspnea. Note that, in this example, the
mediation paths of dyspnea include the path through dyspnea alone and the path through
dyspnea and anxiety sequentially. The conventional PSE, which is led by dyspnea (i.e.,
(𝑆0)

𝑃𝑆𝐸1

), accounts for 35.6% of ACE. In the reclassify FMI strategy, 52.4% of ACE is
(𝑆2)

attributable to the mediation path of dyspnea (i.e., 𝑃𝑆𝐸1

). These results demonstrate the

essential role of dyspnea severity in the relationship between lung function and poor health
status.
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Figure. 4. Causal diagram of the illustrated example

Table 2. Descriptive statistics of variables in the application.

Confounder
0: Netherlands
Country {
1: Switzerland
0: male
Gender {
1: female
Age
BMI
Smoking (pack-year)
𝑀1
Dyspnea score
(the higher, the better)
𝑀2
Anxiety score
(the higher, the more anxious)
Outcome
Feeling thermometer score
(the higher, the better)

Case (FEV1 < 50%)
(N = 74)

Control (FEV1 > 50%)
(N = 146)

N = 35 (47.3%)
N = 39 (52.7%)
N = 41 (55.41%)
N = 33 (44.59%)
Mean = 66.1
(SD = 8.98)
Mean = 25.92
(SD = 4.59)
Mean = 44.26
(SD = 26.77)

N = 78 (53.42%)
N = 68 (46.58%)
N = 88 (60.27%)
N = 58 (39.73%)
Mean = 66.5
(SD = 9.12)
Mean = 26.83
(SD = 5.42)
Mean = 44.48
(SD = 27.6)

Mean = 4.136
(SD = 1.515)

Mean = 5.296
(SD = 1.443)

Mean = 5.027
(SD = 4.629)

Mean = 4.541
(SD = 4.141)

Mean = 57.7
(SD = 17.91)

Mean = 69.73
(SD = 15.8)

Abbreviation: FEV: forced expiratory volume in one second; SD: standard deviation

Table 3. Estimated PSEs via conventional approach and Strategies 1 and 2 in the application.
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Method

Estimate

SD

95% CI

P-value

2.486
1.404
1.170

(1,697, 11.443)
(1.529, 7.034)
(-1.132, 3.455)

0.0082
0.0023
0.3210

6.57
4.281
-0.852
2.013

2.486
1.404
1.253
0.945

(1,697, 11.443)
(1.529, 7.034)
(-3.308, 1.605)
(0.161, 3.864)

0.0082
0.0023
0.4969
0.0331

(𝑆2)
𝑃𝑆𝐸1
(𝑆2)
𝑃𝑆𝐸2

6.57
6.294
-0.852

2.486
1.472
1.253

(1.697, 11.443)
(3.409, 9.180)
(-3.308, 1.605)

0.0082
< 0.0001
0.4969

Average casual effect

12.012

2.428

(7.254, 16.772)

< 0.0001

Sequential effect decomposition
(𝑆0)
6.57
𝑃𝑆𝐸0
(𝑆0)
4.281
𝑃𝑆𝐸1
(𝑆0)
1.161
𝑃𝑆𝐸2
Isolate FMI strategy
(𝑆1)

𝑃𝑆𝐸0

(𝑆1)
𝑃𝑆𝐸1
(𝑆1)
𝑃𝑆𝐸2

FMI
Reclassify FMI strategy
(𝑆2)

𝑃𝑆𝐸0

Abbreviation: CI: confidence interval; SD, standard deviation; PSE: path-specific effect

Discussion
We first discussed why causal misinterpretation is problematic in conventional sequential effect
decomposition. To address this misinterpretation problem, we proposed two strategies, isolate
FMI and reclassify FMI. The isolate FMI strategy provides relatively more details about the
interpretation mechanism, and the reclassify FMI strategy has the advantage of higher accuracy
in interpreting the results of causal mediation analysis with multiple mediators. Generally, we
recommend the isolate FMI strategy for analysis of a parallel mediator relationship since the
presence of FMIpure purely represents the effects of the mediated interaction between 𝑀1
and 𝑀2 on 𝑌. In contrast, for a causally ordered mediation structure, the choice between the
isolate FMI strategy and the reclassify FMI strategy depends on how detailed an analysis the
researchers require. For example, in the COPD study, if the assessment of the mediated
interactive effect between dyspnea and anxiety is not the primary goal, use of the reclassify
FMI strategy is suggested for evaluating effects mediated through the paths led by dyspnea and
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anxiety.
Notably, FMI does not capture all mediated interactions present in the system. The FMI
only includes mediated interactions involving both 𝑀1 and 𝑀2 . Other mediated interactions
are dispersed in PSEs. This research did not decompose the effects of mediated interactions in
PSEs because these effects are classified correctly. Finally, we note that this illustrative example
is likely to be overly simplistic since the assumptions for identification may well be violated.
For example, personal behavior may affect the severity of anxiety and health status. That is,
personal behavior is a potential confounder between 𝑀2 and 𝑌, which was not controlled in
this study. Fortunately, our analysis controlled for a surrogate of personal behavior, i.e.,
smoking behavior. This substitution may not be perfect, but it is reasonable.
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